GLIDE
The Testing Coordinator at GLIDE serves as the lead laboratory technician overseeing day-to-day HIV, Hepatitis C, and STI testing operations in both on-site and community-based settings. The role ensures accurate and compliant delivery of CLIA-waived and moderate complexity tests, including phlebotomy, specimen processing, and documentation. This position also manages data and reporting requirements, maintains supply inventories, and supports research-related specimen activities. The coordinator works closely with internal teams and community partners to support citywide testing efforts and linkage to care within a harm reduction framework.
Headquarters
San Francisco, California, United States
Company Size
51-200 employees
Founded
1963
GLIDE is a San Francisco–based nonprofit (founded in 1963) centered in the Tenderloin that delivers compassionate, sustained, comprehensive care to people experiencing poverty, homelessness, addiction, and marginalization. Its programs include daily community meals, housing and benefits navigation, primary and behavioral healthcare, addiction recovery, job training and education, and legal and social supports. Rooted in the legacy of Glide Memorial Church, GLIDE pairs direct services with cultural programming and advocacy to promote individual and collective transformation, dignity, and belonging. The organization is known for an inclusive, nonjudgmental approach that builds community through ongoing support and celebration.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for GLIDE.
GLIDE didn’t post a salary, so this is our estimate from similar listings.
Chinese company builds 'dirt cheap' hypersonic glide at production cost as low as $99,000: Report
Dec 4, 2025